These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 1326621)

  • 1. Nalbuphine, a mixed kappa 1 and kappa 3 analgesic in mice.
    Pick CG; Paul D; Pasternak GW
    J Pharmacol Exp Ther; 1992 Sep; 262(3):1044-50. PubMed ID: 1326621
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mu antagonist and kappa agonist properties of beta-funaltrexamine (beta-FNA) in vivo: long-lasting spinal analgesia in mice.
    Qi JA; Heyman JS; Sheldon RJ; Koslo RJ; Porreca F
    J Pharmacol Exp Ther; 1990 Mar; 252(3):1006-11. PubMed ID: 2156986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Naloxone benzoylhydrazone (NalBzoH) analgesia.
    Paul D; Levison JA; Howard DH; Pick CG; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1990 Nov; 255(2):769-74. PubMed ID: 2173757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heroin acts on different opioid receptors than morphine in Swiss Webster and ICR mice to produce antinociception.
    Rady JJ; Roerig SC; Fujimoto JM
    J Pharmacol Exp Ther; 1991 Feb; 256(2):448-57. PubMed ID: 1847196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacological characterization of nalorphine, a kappa 3 analgesic.
    Paul D; Pick CG; Tive LA; Pasternak GW
    J Pharmacol Exp Ther; 1991 Apr; 257(1):1-7. PubMed ID: 1850462
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for the interaction of morphine with kappa and delta opioid receptors to induce analgesia in beta-funaltrexamine-treated mice.
    Takemori AE; Portoghese PS
    J Pharmacol Exp Ther; 1987 Oct; 243(1):91-4. PubMed ID: 2822908
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Independent expression of two pharmacologically distinct supraspinal mu analgesic systems in genetically different mouse strains.
    Pick CG; Nejat RJ; Pasternak GW
    J Pharmacol Exp Ther; 1993 Apr; 265(1):166-71. PubMed ID: 8386234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative involvement of mu, kappa and delta receptor mechanisms in opiate-mediated antinociception in mice.
    Ward SJ; Takemori AE
    J Pharmacol Exp Ther; 1983 Mar; 224(3):525-30. PubMed ID: 6131119
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Examination of the involvement of supraspinal and spinal mu and delta opioid receptors in analgesia using the mu receptor deficient CXBK mouse.
    Vaught JL; Mathiasen JR; Raffa RB
    J Pharmacol Exp Ther; 1988 Apr; 245(1):13-6. PubMed ID: 2834533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Involvement of spinal kappa opioid receptors in the antinociception produced by intrathecally administered corticotropin-releasing factor in mice.
    Song ZH; Takemori AE
    J Pharmacol Exp Ther; 1990 Aug; 254(2):363-8. PubMed ID: 2166788
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opioid receptor selectivity of heroin given intracerebroventricularly differs in six strains of inbred mice.
    Rady JJ; Elmer GI; Fujimoto JM
    J Pharmacol Exp Ther; 1999 Feb; 288(2):438-45. PubMed ID: 9918543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of mu and delta receptors in the supraspinal and spinal analgesic effects of [D-Pen2, D-Pen5]enkephalin in the mouse.
    Porreca F; Heyman JS; Mosberg HI; Omnaas JR; Vaught JL
    J Pharmacol Exp Ther; 1987 May; 241(2):393-400. PubMed ID: 3033214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intrathecal beta-funaltrexamine antagonizes intracerebroventricular beta-endorphin- but not morphine-induced analgesia in mice.
    Suh HH; Tseng LF
    J Pharmacol Exp Ther; 1988 May; 245(2):587-93. PubMed ID: 2966856
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In vivo pharmacological characterization of SoRI 9409, a nonpeptidic opioid mu-agonist/delta-antagonist that produces limited antinociceptive tolerance and attenuates morphine physical dependence.
    Wells JL; Bartlett JL; Ananthan S; Bilsky EJ
    J Pharmacol Exp Ther; 2001 May; 297(2):597-605. PubMed ID: 11303048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nalbuphine: an autoradiographic opioid receptor binding profile in the central nervous system of an agonist/antagonist analgesic.
    De Souza EB; Schmidt WK; Kuhar MJ
    J Pharmacol Exp Ther; 1988 Jan; 244(1):391-402. PubMed ID: 2826773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Spinal interactions between opioid and noradrenergic agonists in mice: multiplicativity involves delta and alpha-2 receptors.
    Roerig SC; Lei S; Kitto K; Hylden JK; Wilcox GL
    J Pharmacol Exp Ther; 1992 Jul; 262(1):365-74. PubMed ID: 1378095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of mu, delta and kappa opioid receptors in spinal and supraspinal mediation of gastrointestinal transit effects and hot-plate analgesia in the mouse.
    Porreca F; Mosberg HI; Hurst R; Hruby VJ; Burks TF
    J Pharmacol Exp Ther; 1984 Aug; 230(2):341-8. PubMed ID: 6086883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of beta-funaltrexamine to determine mu opioid receptor involvement in the analgesic activity of various opioid ligands.
    Zimmerman DM; Leander JD; Reel JK; Hynes MD
    J Pharmacol Exp Ther; 1987 May; 241(2):374-8. PubMed ID: 3033213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Action at the mu receptor is sufficient to explain the supraspinal analgesic effect of opiates.
    Fang FG; Fields HL; Lee NM
    J Pharmacol Exp Ther; 1986 Sep; 238(3):1039-44. PubMed ID: 3018217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacological actions of a novel mixed opiate agonist/antagonist: naloxone benzoylhydrazone.
    Gistrak MA; Paul D; Hahn EF; Pasternak GW
    J Pharmacol Exp Ther; 1989 Nov; 251(2):469-76. PubMed ID: 2553921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.